Norman Schwartz - Aug 26, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: Chairman, President, and CEO, Director, 10%+ Owner
Signature: /s/ Norman Schwartz
Stock symbol: BIO
Transactions as of: Aug 26, 2022
Transactions value $: -$7,550,095
Form type: 4
Date filed: 8/29/2022, 07:45 PM
Previous filing: Nov 23, 2021
Next filing: Sep 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad B Common Stock	Options Exercise	$4.21M	+39.3K	+12.42%	$107.32	355K	Aug 26, 2022	Direct
transaction	BIO	Bio-Rad B Common Stock	Tax liability	-$11.8M	-23.7K	-6.68%	$495.28	332K	Aug 26, 2022	Direct
holding	BIO	Bio-Rad B Common Stock						12.9K	Aug 26, 2022	By Spouse	F1
holding	BIO	Bio-Rad B Common Stock						4.06M	Aug 26, 2022	By Blue Raven Partners, L.P.	F2
holding	BIO	Bio-Rad A Common Stock						424K	Aug 26, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-39.3K	-100%	$0.00^*	0	Aug 26, 2022	Bio-Rad B Common Stock	39.3K	$107.32	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person disclaims beneficial ownership of these shares.
F2	The shares are held by a limited partnership of which the reporting person is a limited and general partner. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
F3	The option, representing a right to purchase a total of 39,250 shares, became exercisable in five equal annual installments beginning on September 12, 2013, which was the first anniversary of the date on which the option was granted.